rethinkPeptides Search
Menu
Study breakdown

Testosterone Boosts GH and IGF-1 in Older Men But Doesn't Enhance GHRP-2 Response

RCTStrong evidence
The takeaway

Testosterone supplementation in healthy older men increased basal GH and IGF-1 secretion but did NOT potentiate the GH response to GHRP-2/GHRH peptide stimulation — testosterone works through different GH pathways than secretagogues.

Key finding

Testosterone supplementation increased GH and IGF-1 in healthy older men through enhanced basal secretion but did not potentiate GHRP-2 or GHRH stimul

What the researchers found

Testosterone supplementation increased GH and IGF-1 in healthy older men through enhanced basal secretion but did not potentiate GHRP-2 or GHRH stimulation responses — testosterone and GH secretagogues work through independent, non-synergistic GH-axis pathways.

Why it matters

Relevant for ghrp, hormone-optimization.

How the study worked

RCT study on ghrp, hormone-optimization.

What this study cannot tell us

See abstract.

How to read the evidence

strong evidence.

When this study was published

Published in 2005.

The bigger picture

Advances peptide/biomarker research.

Questions still open

  • Further research needed.
  • Clinical translation to evaluate.

Common questions

What was studied?
Testosterone Boosts GH and IGF-1 in Older Men But Doesn't Enhance GHRP-2 Response
What was found?
Testosterone supplementation in healthy older men increased basal GH and IGF-1 secretion but did NOT potentiate the GH response to GHRP-2/GHRH peptide stimulation — testosterone works through different GH pathways than secretagogues.

Read the original research

Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.

European journal of endocrinology, 153(4), 577-86

Citation

Veldhuis, Johannes D; Keenan, Daniel M; Mielke, Kristi; Miles, John M; Bowers, Cyril Y. (2005). Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.. European journal of endocrinology, 153(4), 577-86.